Skip to content

Effectiveness of cognitive-behavioral Intervention on menopausal hot flashes

Comparison of the effectiveness of cognitive-behavioral approach with two methods of guided self-help and group counseling on problematic hot flashes in menopause

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017101135980N2
Enrollment
150
Registered
2017-10-24
Start date
2017-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal Hot flushes. N95.1

Interventions

Intervention 1: Individuals with inclusion criteria are randomly divided into three groups: Guided Self-Help, group counseling, control group. Counseling sessions for the CBT group: 4 weekly counseli
Behavior
Individuals with inclusion criteria are randomly divided into three groups: Guided Self-Help, group counseling, control group. Counseling sessions for the CBT group: 4 weekly counseling sessions for
Counseling for guide self-help CBT group:Includes an educational session and a telephone counseling, 2 weeks after the start of the study. The participants in this group, Buccett and CD will receive e
The control group does not receive cognitive-behavioral counseling, but in order to reduce the error in the research, the control group will receive 4 weekly training sessions on menstrual bleeding an

Sponsors

Vice chancellor for research, Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: postmenopausal women aged 45-60; problem flushing (score higher than 2 in HFRS and at least 10 hot flashes per week for at least one month before intervention); end of hormone therapy at least 2 months before randomization; women To treat HF ??/ NS, they still mark and seek further treatment; persian language. Exclusion criteria: non-hormone therapies such as clonidine, Megace (megestrol acetate); selective serotonin reuptake inhibitors (SSRIs); physical or mental disabilities that affect the ability of one's participation; women under hormone therapy; Symptoms of hot flush such as hyperthyroidism, pheochromocytoma and carcinoid syndrome.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Amount problematic hot flashes in menopause. Timepoint: Before the intervention, immediately after the intervention, 8 weeks after the intervention, 5 months after the intervention. Method of measurement: Hot Flush Problem-Rating Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoltani Fatemeh

Shahroud University of Medical Sciences

pajoohesh@shmu.ac.ir+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026